Drugs / glargine insulin
glargine insulin
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT07588906 | Feb → Jul 2024 | — | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00640991 | Apr 2008 → Jun 2010 | hyperglycemia, myocardial infarction | Population Health Research Institute | Completed | No outcome recorded |
| Phase 3 | NCT00222521 | Apr 2003 → Aug 2005 | cystic fibrosis-related diabetes | University of Minnesota | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT02451917 | Dec 2013 → Aug 2016 | chronic kidney disease, type 2 diabetes mellitus | University of Sao Paulo General Hospital | Completed | Mixed |
| Phase 4 | NCT00340613 | Jun 2006 → Jun 2007 | type 1 diabetes mellitus | Baylor College of Medicine | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01045954 | Jan → Aug 2010 | type 1 diabetes mellitus | Diabetes Care Center | Unknown | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 3 | NCT01792830 Comparator | Oct 2012 → Feb 2014 | glucose metabolism disease | Emory University | Completed | No outcome recorded |
| Phase 4 | NCT02216799 Comparator | Mar 2013 → Aug 2015 | — | King Faisal Specialist Hospital & Research Center | Completed | No outcome recorded |
| Phase 4 | NCT01203774 Comparator | Sep 2010 → Aug 2013 | diabetes mellitus | University of Colorado, Denver | Completed | No outcome recorded |
| Phase 4 | NCT01211730 Comparator | Apr 2009 → Dec 2015 | hyperglycemia | Northwestern University | Completed | No outcome recorded |
| Phase 4 | NCT00353834 Comparator | Aug 2006 → Sep 2010 | type 2 diabetes mellitus | Joslin Diabetes Center | Completed | No outcome recorded |
| — | NCT00609986 Comparator | Jul 2007 → Oct 2010 | diabetes mellitus, hyperglycemia | Medical University of South Carolina | Completed | No outcome recorded |
Press releases naming this drug 7 releases
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 14 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glargine insulin | “glargine insulin” NCT01211730 ↗ |
| Known as | glargine U100 | “The purpose of this study was to compare the glycemic response to treatment with glargine U100 or neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes...” PMID 31383366 ↗ Aug 2019 |
| Known as | insulin glargine | “Treatment with insulin glargine reduced the incidence of confirmed hypoglycaemia and confirmed nocturnal hypoglycaemia.” PMID 33166419 ↗ Nov 2020 |
| Known as | LANTUS (insulin glargine [rDNA origin] injection | “LANTUS (insulin glargine [rDNA origin] injection” NCT02216799 ↗ |
| Modality | Protein / enzyme biologic | “Glargine is a recombinant human insulin analog” NCT01792830 ↗ |
| Route | Subcutaneous | “The NPH or glargine and aspartame insulin will be given subcutaneously using a small-short needle to administer the insulin.” NCT00609986 ↗ |